Alkermes
ALKS
#2942
Rank
C$7.61 B
Marketcap
C$46.13
Share price
-2.84%
Change (1 day)
-0.58%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): C$0.57 Billion

According to Alkermes's latest financial reports the company's current earnings are C$1.52 Billion. In 2024 the company made an earning of C$0.63 Billion a decrease over its 2023 earnings that were of C$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.57 B-10.2%
2024 C$0.63 B-17.97%
2023 C$0.77 B-468.52%
2022 -C$0.21 Billion449.24%
2021 -C$38.24 Million-68.04%
2020 -C$0.12 Billion-52.1%
2019 -C$0.25 Billion64.49%
2018 -C$0.16 Billion-15.04%
2017 -C$0.18 Billion-34.2%
2016 -C$0.28 Billion-5.34%
2015 -C$0.29 Billion35084.97%
2014 -C$0.82 Million
2012 C$10.1 M-117.81%
2011 -C$56.75 Million-12.69%
2010 -C$64.99 Million94.3%
2009 -C$33.45 Million-117.7%
2008 C$0.18 B622.63%
2007 C$26.15 M
2004 -C$0.11 Billion-14.48%
2003 -C$0.13 Billion11.88%
2002 -C$0.11 Billion39.65%
2001 -C$77.41 Million5.73%
2000 -C$73.21 Million-28.91%
1999 -C$0.11 Billion237.28%
1998 -C$30.54 Million100.05%
1997 -C$15.27 Million-37.93%
1996 -C$24.59 Million82.72%
1995 -C$13.46 Million-26.79%
1994 -C$18.38 Million-72.78%
1993 -C$67.53 Million208.07%
1992 -C$21.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.10 B 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.35 B 3,947.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$16.13 B 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.38 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$10.93 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$17.81 B 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-C$0.29 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-C$0.37 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.41 B 336.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel